Simulations Plus, Inc. (SLP): Price and Financial Metrics


Simulations Plus, Inc. (SLP)

Today's Latest Price: $49.96 USD

2.20 (4.61%)

Updated Jun 5 11:37am

Add SLP to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 47 in Software - Business

See all "A" rated Strong Buy stocks

SLP Stock Summary

  • SLP's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 702.14 -- higher than 94.69% of US-listed equities with positive expected earnings growth.
  • The price/operating cash flow metric for Simulations Plus Inc is higher than 96.96% of stocks in our set with a positive cash flow.
  • SLP's price/sales ratio is 22.5; that's higher than the P/S ratio of 93.88% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Simulations Plus Inc are OMCL, ECOM, SPSC, IRMD, and NTIC.
  • SLP's SEC filings can be seen here. And to visit Simulations Plus Inc's official web site, go to www.simulations-plus.com.
SLP Daily Price Range
SLP 52-Week Price Range

SLP Stock Price Chart More Charts


SLP Price/Volume Stats

Current price $49.96 52-week high $53.76
Prev. close $47.76 52-week low $24.84
Day low $47.63 Volume 63,494
Day high $50.30 Avg. volume 190,350
50-day MA $39.71 Dividend yield 0.5%
200-day MA $35.41 Market Cap 887.69M

Simulations Plus, Inc. (SLP) Company Bio


Simulations Plus develops and produces software for use in pharmaceutical research and for education, and provides consulting and contract research services to the pharmaceutical industry. The company was founded in 1996 and is based in Lancaster, California.

SLP Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$49.96$42.19-15%

Below please find a table outlining a discounted cash flow forecast for SLP, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Simulations Plus Inc ranked in the 45th percentile in terms of potential gain offered. Our DCF analysis suggests the stock is overvalued by about 14.67%. In terms of the factors that were most noteworthy in this DCF analysis for SLP, they are:

  • The company has produced more trailing twelve month cash flow than only 15.41% of its sector Technology.
  • The business' balance sheet reveals debt to be 0% of the company's capital (with equity being the remaining amount). Approximately just 1.94% of US stocks with free cash flow have a lower reliance on debt in their capital structure.
  • SLP's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 64.51% of tickers in our DCF set.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-17%
1%-16%
2%-15%
3%-14%
4%-13%
5%-13%

For other companies in the Technology that have a similar discounted cashflow valuation profile (and ensuing price forecasts) as SLP, try KLAC, MTCH, NVDA, RMBS, and UI.


SLP Latest News Stream


Event/TimeNews Detail
Loading, please wait...

SLP Latest Social Stream


Loading social stream, please wait...

View Full SLP Social Stream

Latest SLP News From Around the Web

Below are the latest news stories about Simulations Plus Inc that investors may wish to consider to help them evaluate SLP as an investment opportunity.

Edited Transcript of SLP earnings conference call or presentation 9-Apr-20 8:15pm GMT

Q2 2020 Simulations Plus Inc Earnings Call

Yahoo | June 3, 2020

Simulations Plus Receives New Grant Award from the FDA

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that it has received a new Grant Award from the FDA to enhance the ocular (OCAT) model in its GastroPlus software.

Business Wire | May 28, 2020

Hudson Pacific Properties Set to Join S&P MidCap 400; Diversified Healthcare Trust, Palomar Holdings & Simulations Plus to Join S&P SmallCap 600

S&P; Dow Jones Indices will make the following changes to the S&P; MidCap 400 and S&P; SmallCap 600 effective prior to the open of trading on Monday, June 1:

Yahoo | May 27, 2020

Simulations Plus to Present at 17th Annual Craig-Hallum Institutional Investor Conference

Simulations Plus announced that CEO Shawn O'Connor will present at the virtual 17th Annual Craig-Hallum Institutional Investor Conference on May 27.

Yahoo | May 21, 2020

Simulations Plus (NASDAQ:SLP) Has Rewarded Shareholders With An Exceptional 602% Total Return On Their Investment

Buying shares in the best businesses can build meaningful wealth for you and your family. While the best companies are...

Yahoo | May 15, 2020

Read More 'SLP' Stories Here

SLP Price Returns

1-mo 29.73%
3-mo 40.22%
6-mo 53.89%
1-year 100.78%
3-year 317.99%
5-year 835.22%
YTD 72.41%
2019 47.45%
2018 25.26%
2017 69.51%
2016 -0.44%
2015 52.77%

SLP Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full SLP Dividend History

Continue Researching SLP

Here are a few links from around the web to help you further your research on Simulations Plus Inc's stock as an investment opportunity:

Simulations Plus Inc (SLP) Stock Price | Nasdaq
Simulations Plus Inc (SLP) Stock Quote, History and News - Yahoo Finance
Simulations Plus Inc (SLP) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9757 seconds.